V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007850 | 290005148 | 1.74 | 83 | Palliative (P) | 2016-10-15 | 2016-10-15 | LANREOTIDE | 02 | N | 290020769 | CARBOPLATIN + ETOPOSIDE |
| 290007851 | 290005150 | 1.76 | 77.7 | Palliative (P) | 2018-06-17 | 2018-06-17 | Docetaxel 75mg/m2 (21 day) | 2 | N | 290020777 | PEMBROLIZUMAB |
| 290007852 | 290005153 | 1.5 | 47 | Palliative (P) | 2017-01-05 | 2017-01-11 | CAPECITABINE + OXALIPLATIN | 2 | N | 290020786 | CAPECITABINE + IRINOTECAN |
| 290007853 | 290007171 | 1.57 | 63.4 | Palliative (P) | 2017-06-11 | 2017-07-08 | CISPLATIN + RT | 02 | N | 290020787 | CAPECITABINE |
| 290007854 | 290005165 | 1.55 | 45.9 | Palliative (P) | 2015-11-10 | 2016-09-14 | Cisplatin 7 day | N | null | 290020855 | PACLITAXEL |
| 290007855 | 290007986 | 1.65 | 71.6 | Palliative (P) | 2014-12-26 | 2014-12-30 | Carboplatin AUC 6 - 10 | 02 | N | 290020874 | CAPECITABINE + CISPLATIN |
| 290007856 | 290005171 | 1.58 | 45.5 | Palliative (P) | null | 2015-12-16 | Capecitabine 35days + RT | 2 | N | 290020891 | TRIFLURIDINE + TIPIRACIL |
| 290007857 | 290007180 | 1.6 | 55 | Palliative (P) | 2019-02-04 | 2019-02-06 | Capecitabine + Cisplatin + RT | 02 | N | 290020928 | CARBOPLATIN |
| 290007858 | 290007180 | 1.61 | 62.3 | Palliative (P) | null | 2015-01-15 | FLUOROURACIL + MITOMYCIN | N | null | 290020928 | CYCLOPHOSPHAMIDE |
| 290007859 | 290005175 | 1.73 | 52 | Palliative (P) | 2016-11-10 | 2016-11-15 | Gemcitabine weekly | 02 | N | 290020932 | PACLITAXEL |
| 290007860 | 290005176 | 1.87 | null | null | 2015-10-03 | 2017-04-29 | Trial Unspecified | 02 | N | 290020933 | CAPECITABINE + CARBOPLATIN |
| 290007861 | 290005180 | 1.57 | 82.9 | Curative (C) | 2017-12-31 | 2018-01-14 | Capecitabine + Oxaliplatin 21day | 02 | N | 290020967 | TRIAL |
| 290007862 | 290005181 | null | null | Adjuvant (A) | 2017-06-11 | 2017-06-11 | Capecitabine (21days) + Carboplatin | null | null | 290020970 | CAPECITABINE + OXALIPLATIN |
| 290007863 | 290005183 | 1.51 | 82.9 | Disease modification (D) | 2015-05-16 | 2015-10-10 | Fluorouracil PVI + Mitomycin 21day | N | y | 290020983 | LANREOTIDE |
| 290007864 | 290005185 | 1.52 | 53.7 | Curative (C) | 2014-04-25 | 2014-05-03 | Everolimus 10mg | 02 | N | 290021002 | CISPLATIN + RT |
| 290007865 | 290007189 | null | 84.25 | Curative (C) | 2013-05-25 | 2015-02-10 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | Y | 290021011 | CISPLATIN + RT |
| 290007866 | 290005187 | 1.84 | 50.2 | Curative (C) | null | 2015-07-17 | Trastuzumab + VINORELBINE | N | Y | 290021015 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007867 | 290005190 | 1.63 | 33 | Curative (C) | 2018-12-24 | 2019-01-22 | Cisplatin + Fluorouracil + RT 5day | N | N | 290021019 | CAPECITABINE + OXALIPLATIN |
| 290007868 | 290005193 | null | 50 | Palliative (P) | 2017-08-08 | 2017-08-13 | Cisplatin + Docetaxel +Fluorouracil | null | N | 290021035 | SUNITINIB |
| 290007869 | 290005199 | 1.77 | 79.04 | Palliative (P) | 2016-11-28 | 2017-05-08 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 290021050 | CETUXIMAB + CISPLATIN + FU |
| 290007870 | 290005200 | 1.87 | 66 | Palliative (P) | 2016-09-28 | 2016-10-11 | PEMBROLIZUMAB | 02 | N | 290021051 | PEMBROLIZUMAB |
| 290007871 | 290005203 | 1.87 | 82.8 | Curative (C) | 2017-09-04 | 2017-10-20 | Carboplatin AUC 6 - 10 | null | N | 290021099 | FLUOROURACIL + MITOMYCIN |
| 290007872 | 290005205 | null | 51.35 | Palliative (P) | 2014-11-19 | 2014-11-19 | Capecitabine | N | null | 290021101 | TRASTUZUMAB + VINORELBINE |
| 290007873 | 290007996 | 0 | 60.5 | Not known (9) | 2018-09-14 | 2018-09-27 | CARBOPLATIN + VINORELBINE | 02 | N | 290021106 | BORTEZOMIB |
| 290007874 | 290005207 | null | 55.9 | Adjuvant (A) | null | 2013-07-08 | Capecitabine | 02 | N | 290021110 | CAPECITABINE |
| 290007875 | 290005210 | 1.62 | 56.3 | Palliative (P) | 2017-08-27 | 2017-09-03 | Y-90 | null | N | 290021152 | PANITUMUMAB |
| 290007876 | 290005215 | 1.9 | 51.2 | Curative (C) | 2017-07-28 | 2017-12-02 | ECX | 02 | N | 290021171 | CARBOPLATIN |
| 290007877 | 290005217 | 1.69 | 65 | Palliative (P) | 2015-04-03 | 2015-04-03 | Brentuximab Vedotin | 02 | N | 290021172 | HYDROXYCARBAMIDE |
| 290007878 | 290005219 | 1.62 | 54 | Adjuvant (A) | 2013-12-16 | 2014-01-02 | Carboplatin AUC 6 - 10 | N | Y | 290021174 | CETUXIMAB + RT |
| 290007879 | 290005221 | 1.55 | null | Palliative (P) | 2018-01-22 | 2018-04-29 | Carboplatin AUC 6 - 10 | null | null | 290021177 | NOT MATCHED |
| 290007880 | 290005223 | 1.69 | 63.4 | Palliative (P) | 2015-03-19 | 2015-03-19 | INTERAACT trial | 02 | N | 290021181 | FLUOROURACIL + MITOMYCIN |
| 290007881 | 290007998 | 1.74 | 73 | Curative (C) | 2013-11-18 | 2014-02-18 | CAPECITABINE + CARBOPLATIN | N | N | 290021194 | CISPLATIN + RT |
| 290007883 | 290005227 | 1.9 | 76 | Palliative (P) | 2015-07-16 | 2015-07-17 | Capecitabine (14 day) + Irinotecan | N | N | 290021207 | CARBOPLATIN + DACARBAZINE |
| 290007884 | 290005228 | 1.89 | 0 | Curative (C) | 2015-02-06 | 2015-02-09 | Capecitabine (21 day) + Irinotecan | 02 | N | 290021208 | CARBOPLATIN + ETOPOSIDE |
| 290007885 | 290008000 | null | 86 | Palliative (P) | 2017-02-06 | 2017-03-24 | Capecitabine + Oxaliplatin 21day | N | N | 290021215 | CAPECITABINE + OXALIPLATIN |
| 290007886 | 290005235 | 1.74 | null | null | 2018-03-09 | 2018-03-30 | DHAP - R | null | N | 290021246 | CAPECITABINE + OXALIPLATIN |
| 290007887 | 290005236 | 1.59 | 55 | Curative (C) | 2015-12-21 | 2015-12-26 | Cetuximab + FOLFIRI cycle1 | 02 | Y | 290021248 | CAPECITABINE + RT |
| 290007888 | 290005243 | 1.64 | 139 | Curative (C) | 2015-07-25 | 2015-07-25 | LANREOTIDE | N | N | 290021277 | CISPLATIN |
| 290007890 | 290005248 | 1.76 | null | Curative (C) | 2017-08-18 | 2017-08-25 | INTERAACT trial | Y | N | 290021289 | CETUXIMAB + RT |
| 290007891 | 290005249 | null | null | Palliative (P) | 2015-11-09 | 2015-11-16 | CETUXIMAB | N | N | 290021292 | CARBOPLATIN + PACLITAXEL |
| 290007892 | 290008460 | 1.8 | 116.7 | Palliative (P) | 2016-04-18 | 2016-05-02 | LANREOTIDE | N | N | 290021304 | TRABECTEDIN |
| 290007893 | 290005251 | 1.68 | 81.5 | Neo-adjuvant (N) | 2016-08-04 | 2016-08-04 | MITOMYCIN | Y | N | 290021310 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007894 | 290005255 | 1.84 | 67 | Palliative (P) | 2016-01-24 | 2016-01-25 | Capecitabine + Cisplatin | null | N | 290021325 | EOX |
| 290007895 | 290005257 | 1.63 | 44.1 | Palliative (P) | 2016-07-24 | 2016-09-13 | Capecitabine | N | N | 290021334 | CARBOPLATIN + PACLITAXEL |
| 290007896 | 290005258 | 1.6 | null | Palliative (P) | 2019-06-15 | 2019-08-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 290021338 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007897 | 290008414 | 1.73 | 80 | Disease modification (D) | 2017-03-19 | 2017-04-17 | LANREOTIDE | 2 | N | 290021347 | OCTREOTIDE |
| 290007898 | 290007225 | 1.78 | 43.9 | null | null | 2017-12-29 | CAPECITABINE + CARBOPLATIN + Cetuximab | 02 | N | 290021387 | CARBOPLATIN + PACLITAXEL + RT |
| 290007899 | 290005265 | 1.72 | 48.3 | Curative (C) | 2016-02-23 | 2016-03-14 | Folfirinox | N | N | 290021389 | CARBOPLATIN + ETOPOSIDE |
| 290007900 | 290007231 | 1.68 | 46 | Palliative (P) | 2012-12-11 | 2014-06-23 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 02 | null | 290021421 | CAPECITABINE + CISPLATIN |
| 290007901 | 290005275 | 1.79 | 65 | Palliative (P) | 2015-03-01 | 2015-03-12 | Capecitabine + Cisplatin | 02 | N | 290021425 | CAPECITABINE |